In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat

[1]  C. J. Schmidt,et al.  Role of dopamine in the neurotoxic effects of methamphetamine. , 1985, The Journal of pharmacology and experimental therapeutics.

[2]  C. J. Schmidt,et al.  Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. , 1985, European journal of pharmacology.

[3]  C. J. Schmidt,et al.  In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine. , 1984, European journal of pharmacology.

[4]  L. Seiden,et al.  Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine , 1984, Pharmacology Biochemistry and Behavior.

[5]  A. Brossi,et al.  Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs. , 1984, Science.

[6]  G. Cohen.  Oxy-radical toxicity in catecholamine neurons. , 1984, Neurotoxicology.

[7]  D. Godin,et al.  Parkinson's disease: A disorder due to nigral glutathione deficiency? , 1982, Neuroscience Letters.

[8]  R. Fuller,et al.  Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine , 1982, Neuropharmacology.

[9]  J. Gibb,et al.  Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain , 1981, Neuropharmacology.

[10]  J. Gibb,et al.  Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. , 1980, The Journal of pharmacology and experimental therapeutics.

[11]  D. Graham,et al.  Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.

[12]  D. Graham.  Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. , 1978, Molecular pharmacology.

[13]  D. Tse,et al.  Potential oxidative pathways of brain catecholamines. , 1976, Journal of medicinal chemistry.

[14]  L. Iversen.  Inhibition of catecholamine uptake by 6-hydroxydopamine in rat brain. , 1970, European journal of pharmacology.